Is There a Generic Ozempic, Wegovy, Mounjaro, or Zepbound in the US?

Short Answer: No US Generic GLP-1 Is on Pharmacy Shelves Yet

No. As of 2026-07-07, US patients should not expect to buy an FDA-approved generic Ozempic, Wegovy, Mounjaro, or Zepbound at an ordinary pharmacy. Semaglutide and tirzepatide are generic ingredient names, but that is not the same thing as an FDA-approved finished generic product available for sale.

There are real generic milestones, just not pharmacy availability. Apotex announced on 2026-04-10 that it received the first US FDA tentative approval for a generic semaglutide injection referencing Ozempic. Tentative approval means tentative approval, not pharmacy availability. The product cannot be marketed until remaining patent or exclusivity barriers are resolved.

Sandoz announced on 2026-06-29 that FDA accepted two ANDAs for proposed generic tirzepatide autoinjectors referencing Mounjaro and Zepbound. That is application acceptance for review. It is not approval, final approval, launch, price disclosure, or pharmacy stock.

If you need lower-cost access now, compare real current paths instead of chasing a fake generic claim: /blog/glp1-without-insurance, /blog/cheapest-semaglutide-online, /blog/save-money-glp1, /go/skinnyrx, /go/eden-health, /go/medvi, /go/direct-meds, /go/novi, /go/shed, and /go/enhancedmd.

Generic Status Table by Brand

Ozempic: active ingredient semaglutide. It is an FDA-approved brand for type 2 diabetes, cardiovascular risk reduction, and chronic kidney disease. Drugs.com says no FDA-approved generic Ozempic is available. Apotex has a tentative approval for generic semaglutide injection referencing Ozempic, but that is not a launch.

Wegovy: active ingredient semaglutide. It is the obesity and weight-management brand. No confirmed purchasable FDA-approved generic Wegovy is available in the US. Do not treat Apotex's Ozempic-referenced tentative approval as a generic Wegovy launch.

Mounjaro: active ingredient tirzepatide. It is the diabetes brand. Drugs.com says no FDA-approved generic Mounjaro is available. Sandoz says its FDA-accepted ANDA references Mounjaro, but the product is only under review.

Zepbound: active ingredient tirzepatide. It is the chronic weight-management and OSA brand. Drugs.com says no FDA-approved generic Zepbound is available. Sandoz says its second FDA-accepted ANDA references Zepbound, but it is still review-stage only.

The rule is simple: ingredient name does not equal FDA-approved generic, and FDA milestone does not automatically equal pharmacy availability.

Tentative Approval vs Final Approval vs Available to Buy

The FDA Orange Book identifies approved drug products, therapeutic equivalence evaluations, and patent and exclusivity information. It is useful because it separates official regulatory status from advertising language.

Tentative approval means FDA has completed enough review to determine that a generic application can meet approval requirements, but the product cannot be marketed until remaining patent or exclusivity blocks are cleared. That is where Apotex's 2026-04-10 semaglutide injection milestone fits.

ANDA acceptance for review is earlier. It means FDA accepted the application into the review process. It does not mean FDA approved the generic, and it does not mean the product can be sold. That is where Sandoz's 2026-06-29 proposed generic tirzepatide autoinjectors fit.

Final approval is stronger, but even final FDA approval does not guarantee same-day pharmacy stock, broad distribution, insurer coverage, or a low launch price. Available to buy is the standard patients actually care about.

If a website says generic Ozempic, generic Wegovy, generic Mounjaro, or generic Zepbound is available today, ask what it means: ingredient name, compounded product, international generic, tentative approval, ANDA filing, or final FDA-approved US product.

Why Canada and Other Countries Cause US Confusion

Canada can have a true generic semaglutide story without creating a US generic Ozempic or Wegovy product. PeptidePub's Canada savings guide says Health Canada approved generic semaglutide injection in April 2026 and a second in May 2026 for adult type 2 diabetes. That matters for Canada, but approval can still run ahead of pharmacy inventory, insurer-loaded DINs, lower pricing, and indication coverage. Use /blog/glp1-savings-canada for that country-specific context.

International patent and regulatory timelines differ by country. A generic semaglutide headline in Canada, India, China, Brazil, or Turkey does not mean the same product can legally be sold as an FDA-approved US generic.

US readers should be especially careful with import or overseas-pharmacy claims. A seller may use real words like semaglutide, tirzepatide, generic, or GLP-1 and still fail the practical test: US FDA-approved product, legitimate prescription, real dispensing pharmacy, verified manufacturer, cold-chain handling, and total delivered price.

This is not individualized legal advice. It is the buyer-safety point that matters before payment: an international generic headline is not proof of lawful, safe, FDA-approved US access.

Compounded GLP-1s Are Not Generics

A compounded semaglutide or tirzepatide prescription may be a legal pharmacy product in some circumstances, but it is not a generic Ozempic, generic Wegovy, generic Mounjaro, or generic Zepbound. Use /blog/compounded-vs-brand-glp1 and /blog/ozempic-vs-compounded-semaglutide for the deeper comparison.

FDA's 2026-04-01 GLP-1 compounding clarification says compounded drugs must meet the conditions in section 503A or 503B. Under 503A, compounded drugs are made for an individual patient after receipt of a valid prescription. Compounders cannot regularly or in inordinate amounts compound products that are essentially copies of commercially available drugs.

For 503B outsourcing facilities, FDA says bulk drug substances are restricted unless the substance appears on the 503B bulks list or the drug is on FDA's shortage list at the time of compounding, distribution, and dispensing. FDA says semaglutide and tirzepatide do not currently appear on the 503B bulks list or FDA drug shortage list.

FDA also says compounded drugs are not FDA-approved finished drugs and are not reviewed by FDA for safety, effectiveness, and quality before marketing. That is the regulatory dividing line. Compounded may be a current access route for some patients. It is not the same as an FDA-approved generic.

Red-Flag Generic Claims Before You Pay

Red flag 1: generic Ozempic now available in the US. Reality: Drugs.com says no FDA-approved generic Ozempic is available, and Apotex's 2026-04-10 milestone is tentative approval, not market launch.

Red flag 2: generic Zepbound or generic Mounjaro now available. Reality: Drugs.com says no FDA-approved generic versions are available, and Sandoz's 2026-06-29 announcement is application acceptance for review, not approval.

Red flag 3: same active ingredient means same FDA-approved drug. Reality: an active ingredient name is not the same as an FDA-approved finished generic product.

Red flag 4: research-use semaglutide or tirzepatide is a generic. Reality: research-use products are not consumer prescriptions and should not be framed as legitimate patient access.

FDA's unapproved GLP-1 safety page, current 2026-06-15, says FDA is aware of fraudulent compounded semaglutide and tirzepatide marketed in the US with false label information. Some labels named pharmacies that did not exist or pharmacies that FDA says did not compound the products.

As of 2026-05-31, FDA had received 990 adverse-event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide, with underreporting likely.

Lower-Cost Options Readers Can Actually Compare Today

If no US generic is available, the useful question changes from "where can I buy generic Ozempic" to "which legitimate access path can I verify before I pay." Start with insurance coverage, manufacturer savings, cash-pay brand programs where available, and carefully vetted telehealth or compounded routes.

PeptidePub comparison pages are the safer next step: /blog/glp1-without-insurance for insurance-free access, /blog/cheapest-semaglutide-online for semaglutide price comparison, /blog/save-money-glp1 for savings strategies, /peptides/semaglutide and /peptides/tirzepatide for molecule-level evidence, and /peptides/orforglipron for oral GLP-1 pipeline context.

Provider links such as /go/skinnyrx, /go/skinnyrx-semaglutide, /go/skinnyrx-tirzepatide, /go/eden-health, /go/medvi, /go/direct-meds, /go/novi, /go/shed, and /go/enhancedmd should be treated as current alternatives, not generic links. They may offer telehealth, cash-pay, brand, or compounded pathways subject to medical eligibility and pharmacy verification.

Before checkout, verify exact medication, brand versus compounded status, pharmacy name, manufacturer when applicable, concentration, total monthly price, dose escalation fees, shipping, supplies, refund if not prescribed, cancellation terms, and side-effect support. Do not assume any provider is selling an FDA-approved generic unless it can prove that exact status.

FAQ

Is there a generic Ozempic in the US? No purchasable FDA-approved generic is available. Apotex announced tentative approval on 2026-04-10, but that is not market availability.

Is there a generic Wegovy? No confirmed purchasable FDA-approved generic Wegovy is available. Semaglutide is the ingredient name, not proof of a Wegovy generic launch.

Is there a generic Mounjaro or Zepbound? No. Sandoz says FDA accepted proposed generic tirzepatide ANDAs for review on 2026-06-29, but review acceptance is not approval.

Is compounded semaglutide a generic Ozempic? No. Compounded prescriptions and FDA-approved generics are different regulatory categories.

Can I buy generic GLP-1s from Canada or overseas? Do not assume an international generic headline means legal US access. Country approvals, patents, import rules, supply, and quality controls differ.

Bottom Line

No US pharmacy-shelf generic Ozempic, Wegovy, Mounjaro, or Zepbound should be assumed available as of 2026-07-07. Apotex and Sandoz matter because they signal future competition, but they do not solve today's access problem. Compare brand savings, cash-pay brand paths, and vetted telehealth or compounded routes with clear pharmacy safeguards. Do not buy a product marketed as generic unless the seller can prove US FDA-approved generic status, legitimate prescription, real pharmacy dispensing, exact product identity, and total price.